Katz M, Kroll D, Pak I, Osimoni A, Hirsch M
Obstet Gynecol. 1985 Dec;66(6):822-4.
The "absolute safety" of bromocriptine as a drug of choice in suppression of lactation is questioned. Two cases of cerebrovascular events after the use of bromocriptine for lactation suppression are presented, and the available, pertinent literature is reviewed.
溴隐亭作为抑制泌乳的首选药物的“绝对安全性”受到质疑。本文介绍了两例使用溴隐亭抑制泌乳后发生脑血管事件的病例,并对现有相关文献进行了综述。